{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:21:33Z","timestamp":1788272493195,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"DOI":"10.1007\/s10620-026-10222-2","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:57:52Z","timestamp":1788271072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-Effectiveness of AI-Enabled Electrocardiography for Screening MASLD-Associated Advanced Chronic Liver Disease in the US Population"],"prefix":"10.1007","author":[{"given":"Basile","family":"Njei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dam","family":"Nsoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Akem","family":"Dimala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yussif","family":"Issaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazan A.","family":"Al-Ajlouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"10222_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology (Baltimore, Md.) 2023;77:1335.","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10222_CR2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"F Tacke","year":"2024","unstructured":"Tacke F et al. EASL\u2013EASD\u2013EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Journal of hepatology 2024;81:492\u2013542.","journal-title":"Journal of hepatology"},{"key":"10222_CR3","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2337\/dci24-0094","volume":"48","author":"K Cusi","year":"2025","unstructured":"Cusi K et al. Metabolic dysfunction\u2013associated steatotic liver disease (MASLD) in people with diabetes: the need for screening and early intervention. A consensus report of the American diabetes association. Diabetes Care 2025;48:1057\u20131082.","journal-title":"Diabetes Care"},{"key":"10222_CR4","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"K Cusi","year":"2022","unstructured":"Cusi K et al. American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD). Endocrine Practice 2022;28:528\u2013562.","journal-title":"Endocrine Practice"},{"key":"10222_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s11606-024-08955-9","volume":"40","author":"TG Xiao","year":"2025","unstructured":"Xiao TG et al. Identifying and Linking Patients At Risk for MASLD with Advanced Fibrosis to Care in Primary Care: Xiao et al. Journal of General Internal Medicine. 2025;40:629\u2013636.","journal-title":"Journal of General Internal Medicine."},{"key":"10222_CR6","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.) 2023;77:1797.","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10222_CR7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2337\/dc24-2075","volume":"48","author":"C Caussy","year":"2025","unstructured":"Caussy C et al. Screening for metabolic dysfunction\u2013associated steatotic liver disease\u2013related advanced fibrosis in diabetology: a prospective multicenter study. Diabetes care 2025;48:877\u2013886.","journal-title":"Diabetes care"},{"key":"10222_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.14309\/ajg.0000000000001617","volume":"117","author":"JC Ahn","year":"2022","unstructured":"Ahn JC et al. Development of the AI-Cirrhosis-ECG (ACE) Score: An electrocardiogram-based deep learning model in cirrhosis. The American journal of gastroenterology 2022;117:424.","journal-title":"The American journal of gastroenterology"},{"key":"10222_CR9","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.14309\/ajg.0000000000003433","volume":"120","author":"P Rattan","year":"2025","unstructured":"Rattan P et al. Training and performance of an electrocardiogram-enabled machine learning model for detection of advanced chronic liver disease. The American journal of gastroenterology 2025;120:2452.","journal-title":"The American journal of gastroenterology"},{"key":"10222_CR10","doi-asserted-by":"crossref","unstructured":"Udompap, P., et al., Performance of AI-enabled electrocardiogram in the prediction of metabolic dysfunction\u2013associated steatotic liver disease. Clinical Gastroenterology and Hepatology, 2025. 23(4): p. 574\u2013582. e3.","DOI":"10.1016\/j.cgh.2024.08.009"},{"key":"10222_CR11","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/oby.70005","volume":"33","author":"A Mohanty","year":"2025","unstructured":"Mohanty A, Wang Y, Stoecker C. Screening for MASLD and Advanced Fibrosis Among Patients With Obesity: A Cost-Effectiveness Analysis. Obesity 2025;33:1845\u20131848.","journal-title":"Obesity"},{"key":"10222_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2025.101789","volume":"30","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM et al. Economic evaluation of non-invasive test pathways for high-risk metabolic dysfunction-associated steatotic liver disease (MASLD) in the United Kingdom (UK). Annals of Hepatology 2025;30:101789.","journal-title":"Annals of Hepatology"},{"key":"10222_CR13","doi-asserted-by":"publisher","first-page":"19336","DOI":"10.1038\/s41598-025-01740-6","volume":"15","author":"M Kim","year":"2025","unstructured":"Kim M et al. Cost-effectiveness analysis of MASLD screening using FIB-4 based two-step algorithm in the medical check-up. Scientific Reports 2025;15:19336.","journal-title":"Scientific Reports"},{"key":"10222_CR14","doi-asserted-by":"crossref","unstructured":"Dimala, C.A., et al., Artificial intelligence-enabled electrocardiography for risk prediction in chronic liver disease: A systematic review. International journal of cardiology, 2025: p. 133926.","DOI":"10.1016\/j.ijcard.2025.133926"},{"key":"10222_CR15","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/liv.14198","volume":"39","author":"C Crossan","year":"2019","unstructured":"Crossan C et al. Referral pathways for patients with NAFLD based on non-invasive fibrosis tests: Diagnostic accuracy and cost analysis. Liver International 2019;39:2052\u20132060.","journal-title":"Liver International"},{"key":"10222_CR16","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/S0168-8278(20)30643-7","volume":"73","author":"D Mansour","year":"2020","unstructured":"Mansour D, Herscovitz M, Cassidy P. Incorporating assessment of liver fibrosis into routine diabetic review in primary care: a pilot. Journal of Hepatology 2020;73:S47\u2013S48.","journal-title":"Journal of Hepatology"},{"key":"10222_CR17","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/hep4.1411","volume":"3","author":"T Davyduke","year":"2019","unstructured":"Davyduke T et al. Impact of implementing a \u201cFIB-4 first\u201d strategy on a pathway for patients with NAFLD referred from primary care. Hepatology communications 2019;3:1322\u20131333.","journal-title":"Hepatology communications"},{"key":"10222_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/liv.15730","volume":"44","author":"R Forlano","year":"2024","unstructured":"Forlano R et al. A prospective study on the prevalence of MASLD in people with type-2 diabetes in the community. Cost effectiveness of screening strategies. Liver International 2024;44:61\u201371.","journal-title":"Liver International"},{"key":"10222_CR19","doi-asserted-by":"publisher","first-page":"24186","DOI":"10.1038\/s41598-025-08434-z","volume":"15","author":"H Park","year":"2025","unstructured":"Park H et al. Cost-effectiveness of advanced hepatic fibrosis screening in individuals with suspected MASLD identified by serologic noninvasive tests. Scientific Reports 2025;15:24186.","journal-title":"Scientific Reports"},{"key":"10222_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000191","volume":"7","author":"L Gruneau","year":"2023","unstructured":"Gruneau L et al. Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver disease. Hepatology Communications 2023;7:e00191.","journal-title":"Hepatology Communications"},{"key":"10222_CR21","doi-asserted-by":"publisher","first-page":"18345","DOI":"10.1038\/s41598-020-75227-x","volume":"10","author":"V Blank","year":"2020","unstructured":"Blank V et al. Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination. Scientific reports 2020;10:18345.","journal-title":"Scientific reports"},{"key":"10222_CR22","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/gutjnl-2021-324243","volume":"71","author":"FE M\u00f3zes","year":"2022","unstructured":"M\u00f3zes FE et al. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut 2022;71:1006\u20131019.","journal-title":"Gut"},{"key":"10222_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41591-025-04058-y","volume":"32","author":"DA Simonetto","year":"2026","unstructured":"Simonetto DA et al. Detection of undiagnosed liver cirrhosis via AI-enabled electrocardiogram: a pragmatic, cluster-randomized clinical trial. Nature Medicine 2026;32:160\u2013167.","journal-title":"Nature Medicine"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10222-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10222-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10222-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:57:53Z","timestamp":1788271073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10222-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":23,"alternative-id":["10222"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10222-2","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"25 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}